ImmuCell Reports 46% Surge in Q3 2026 Preliminary Product Sales

Key Facts

1ImmuCell announced a 46% increase in product sales for the third quarter of 2026 based on preliminary, unaudited results.

ImmuCell announced a 46% increase in product sales for the third quarter of 2026 based on preliminary, unaudited results. The company stated in a GlobeNewswire release that total sales for the three months ended September 30, 2026, reached $8.0 million, compared to the same period in the previous year.

Third-quarter growth was broad-based across the portfolio, with Tri-Shield sales rising 51% and Dual-Force increasing 36%, while domestic sales accounted for $6.9 million. ICCC closed at $9.8 on October 9, 2026, prior to the announcement of these results which brought total sales for the first nine months of the year to $25.6 million.